HomeVYGR • NASDAQ
add
Voyager Therapeutics Inc
Previous close
$7.42
Day range
$7.32 - $7.71
Year range
$6.06 - $14.34
Market cap
412.41M USD
Avg Volume
751.32K
P/E ratio
2.56
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 90.06M | 5,910.39% |
Operating expense | 10.24M | 21.04% |
Net income | 56.40M | 338.70% |
Net profit margin | 62.62 | -95.89% |
Earnings per share | 1.25 | 304.92% |
EBITDA | 55.40M | 333.46% |
Effective tax rate | 1.44% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 230.88M | 94.26% |
Total assets | 351.28M | 120.44% |
Total liabilities | 114.96M | 14.58% |
Total equity | 236.32M | — |
Shares outstanding | 54.30M | — |
Price to book | 1.38 | — |
Return on assets | 41.85% | — |
Return on capital | 59.56% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 56.40M | 338.70% |
Cash from operations | -23.76M | -94.05% |
Cash from investing | 26.83M | 90.75% |
Cash from financing | 460.00K | 66.67% |
Net change in cash | 3.53M | 68.32% |
Free cash flow | -39.68M | -847.26% |
About
Founded
2013
Headquarters
Website
Employees
162